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Summary
 
Older people suffer from a decline in immune system,
which affects their ability to respond to infections and to
raise efficient responses to vaccines. Effective and specific
antibodies in responses from older individuals are
decreased in favour of non-specific antibody production.
We investigated the B-cell repertoire in DNA samples
from peripheral blood of individuals aged 86–94 years,
and a control group aged 19–54 years, using spectratype
analysis of the IGHV complementarity determining region
(CDR)3. We found that a proportion of older individuals
had a dramatic collapse in their B-cell repertoire diversity.
Sequencing of polymerase chain reaction products from
a selection of samples indicated that this loss of diversity
was characterized by clonal expansions of B cells 
 
in vivo.
 
Statistical analysis of the spectratypes enabled objective
comparisons and showed that loss of diversity correlated
very strongly with the general health status of the
individuals; a distorted spectratype can be used to predict
frailty. Correlations with survival and vitamin B12 status
were also seen. We conclude that B-cell diversity can
decrease dramatically with age and may have important
implications for the immune health of older people. B-cell
immune frailty is also a marker of general frailty.
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Introduction
 
Older people suffer from a decline in the immune system that
affects their ability to respond to infections and to raise effective
responses to vaccines (Weinberger 
 
 et al.
 
, 2008). This is
particularly apparent from the high mortality rates due to
pneumonia in the elderly (Office for National Statistics, 2005),
and their susceptibility to hospital-acquired infections, such as
 
Clostridium difficile
 
 and methicillin-resistant 
 
Staphylococcus
aureus
 
 (Health Protection Agency, 2008). Many aspects of the
immune system are altered in immunosenescence. The T-cell
repertoire is decreased, T cells lose responsiveness (Effros 
 
 et al.
 
,
2003; Koch 
 
 et al.
 
, 2006), macrophages have a decreased
antigen-presenting capacity and altered cytokine secretion
(Dace & Apte, 2008), follicular dendritic cells cannot present
antigen as efficiently (Aydar 
 
 et al.
 
, 2004), and neutrophils lose
phagocytic ability (Lord 
 
 et al.
 
, 2001). The humoral immune
system is crucial to the effective response against bacterial
infections such as pneumonia, but its role in immune frailty has
not been well studied. It is known that the quality of the antibody
response changes with age, with a lower level of specific
antibodies and an increased level of non-specific antibodies
being generated in response to vaccination (Howard 
 
 et al.
 
, 2006).
The reasons for this failure, and the increased susceptibility to
bacterial infections, remain to be fully elucidated, but it seems
likely that changes in the humoral immune system would play
a key role in the increased immune frailty of the elderly.
High-affinity specific antibodies are generated during affinity
maturation, a process that takes place in the germinal centre
of secondary lymphoid tissue and is characterized by somatic
hypermutation of Ig genes and subsequent selection of the
genes encoding the best antibodies (MacLennan, 1994). There
have been reports of an increased level of mutations in Ig genes
in older people (Dunn-Walters 
 
 et al.
 
, 1997; Chong 
 
 et al.
 
, 2003).
However, we have shown that the somatic hypermutation
process occurs at the same rate in young and old humans, and
so this difference is more likely a consequence of accumulation
rather than altered rate (Banerjee 
 
 et al.
 
, 2002). We have also
found that the imprint of hypermutation, in terms of the types
of mutations and the hotspots in which they occur, is the same
in samples from both young and elderly individuals, suggesting
that the mechanism of hypermutation does not change with
age (data not shown). Finally, data from our study (Banerjee
 
et al.
 
, 2000) and that of others (Lazuardi 
 
 et al.
 
, 2005) provide
no evidence for age-related changes in the size and number of
germinal centres in humans, although the situation may be
somewhat different in mice (Zheng 
 
 et al.
 
, 1997).
Although the most well-known function of B cells is as
antibody producers, they have intrinsic properties that also
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make a vital contribution to the immune system. They are highly
effective as antigen-presenting cells, and have been shown to
be essential for the development of T-cell memory (Crawford
 
et al.
 
, 2006). There is also now substantial evidence to support
their role as immune regulators, since they are capable of
secreting IL10. IL10-secreting B cells could serve to prevent
inappropriate stimulation of the immune system, such as that
leading to autoimmune disease, and could also serve to limit
the aggressiveness of bona fide immune responses (Fillatreau
 
et al.
 
, 2008). It thereby follows that a loss of diversity in the B-
cell repertoire would be predicted to have dramatic and serious
consequences for the integrity of the humoral immune system.
To date there has been a paucity of evidence regarding changes
in the B-cell repertoire with age. Some contradictory studies
have concentrated on determining whether there is a change
in the relative proportions of the different IGHV gene families
with age (Van Dijk-Hard 
 
 et al.
 
, 1997; Wang & Stollar, 1999),
but since there are only six different IGHV families, and an
estimated 10
 
8
 
 B cells per person, this method of assessing
diversity is less than ideal. Studies focussing on sequencing the
area of the hypervariable complementarity determining three
(CDR3) region of the IGH gene, an area highly important for
antigen binding, have been limited by the logistics of large-scale
sequencing and so have been restricted to small numbers of
individuals and only one subgroup of Ig genes (Xue 
 
 et al.
 
, 1997;
Kolar 
 
et al.
 
, 2006). Because these and other previous studies were
restricted in their ability to measure diversity, we therefore set
out to undertake a comprehensive analysis of B-cell diversity in
the elderly, using as our technique the CDR3 spectratyping of
all IGH genes. The CDR3 region of the Ig heavy chain gene
comprises the area where three different Ig genes (IGHV, IGHD,
IGHJ) join together to make the whole. As such it is highly diverse,
both in sequence and in the length of the sequence. Amplifying
the CDR3 region of the Ig gene using labelled primers and running
the subsequent products on a high-resolution sequencing gel
produces a characteristic spectratype, representing the distribution
of different CDR3 sizes in the sample population. For our study
population, we used peripheral blood mononuclear cell samples
taken from older people in the Swedish NONA longitudinal study
on immunosenescence. This study, and its predecessor (OCTO
study), followed the health and T-cell immune characteristics of
a number of old volunteers and resulted in the discovery of a
T-cell ‘Immune Risk Phenotype’ (IRP) that predicted mortality in
the very old. IRP is characterized by an expansion of CD8
 
+
 
 T cells,
and a resulting inverted CD4
 
+
 
/CD8
 
+
 
 ratio (Wikby 
 
 et al.
 
, 1998, 2002).
Later studies on the same patient group showed that inflammatory
markers, such as IL-6, CRP and albumin, are also significant
predictors of mortality in very old humans (Wikby 
 
 et al.
 
, 2006).
Using an objective measurement of our B-cell spectratypes as
a measure of B-cell diversity, together with additional direct
sequence data, our data revealed a striking collapse in B-cell
diversity in a subset of older individuals in this study that is not
seen in our control samples from young, healthy individuals.
Furthermore, this collapse in B-cell diversity is a biomarker that
is strongly predictive of poor health status (frail vs. healthy) in
the NONA cohort, as well as the likelihood of death within the next
4-year interval. Overall these data reveal a hitherto unexpected
collapse in the humoral immune system with age in some elderly
individuals, with significant implications for their ability to defend
against pathogens and respond to vaccination.
 
Results
 
B-cell diversity can dramatically collapse in some older 
individuals
 
We investigated the diversity of the peripheral blood B-cell popu-
lation in older people using spectratype size analysis of the IGH
CDR3 region (Fig. 1a). A polyclonal B-cell population from a healthy
young individual typically yields a spectratype of CDR3 lengths
in the range 57–117 bp that follows an approximately normal
distribution (top panel in Fig. 1b,c). Although many individuals
in the Swedish longitudinal NONA cohort also show a similar
Fig. 1 Generation of B-cell spectratypes from peripheral blood mononuclear 
cells. (a) Seminested PCR is performed over the CDR3 region (IGHV-IGHD-
IGHJ joining region of the immunoglobulin heavy chain gene), the positions 
of the primers are indicated by the black bars. The 3′ nested primer is labelled 
with 6-Fam. The PCR products are electrophoresed on an ABI377 slab gel 
sequencing system to generate spectratypes (b). The heights of the individual 
peaks were determined and used to generate graphs where each fragment 
size is represented as a percentage of the whole (c). The blue dotted line 
overlaid on the plots represents the median distribution of the young control 
data set (aged 19–55 years). 
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normally distributed spectratype, we observed several samples
where the spectratype was strikingly and reproducibly non-
normal (third and fourth panels in Fig. 1b,c), often due to the
presence of one or more unusually abundant fragment lengths.
To compare multiple spectratypes, the fragment size and
peak height of the initial ABI 377 spectratype data were
quantified, which enable the data to be summarized in graphical
format (Fig. 1c). Using this summarization technique we com-
pared data from blood samples from a younger control group
(28 people, 19–55 years old) with samples from 45 participants
of the NONA study (aged 86, 90 and 94 years). The shape of
the spectratypes varied much more in the older population than
in the younger control group, as can be clearly seen when all
the data are overlayed (Fig. 2a,b).
The presence of peaks of altered height in such spectratypes
distorts the fragment distribution away from a normal (Gaussian)
distribution, such as that seen in the young samples. A number
of parameters could be used to explore these distributional
changes, including skew and kurtosis, or the correlation to a
normal distribution. However, a simple metric that is sensitive
to these distortions is the standard deviation (SD) of the dis-
tribution. This decreases in instances (such as the bottom panels
in Fig. 1b,c) where there is increased peak height in fragments
close to the centre point of the distribution, and increases in
those cases when the peak height increases are in fragment
lengths that are towards the edge of the range. When plotted
vs. age, it is striking that whereas the mean of the SDs of both
the young and NONA samples are approximately equal, the
latter show a significantly wider spread of SD values (Fig. 2c).
The simplest hypothesis is that the altered peak heights
in a distorted spectratype represent reduced B-cell diversity,
together with possible oligoclonal expansions in the B-cell
repertoire. To test this we chose six samples from older individ-
uals for further investigation, two of which had a spectratype
of approximately normal appearance and four that deviated
markedly from a normal distribution. Polymerase chain reaction
(PCR) products from these samples were sequenced in order to
more closely examine the diversity of the population (Fig. 3). In
the samples that showed distorted (non-normal) spectratypes,
we observed multiple independent identical, or near-identical,
sequences (Fig. 3). In addition there are some sequences that
have the same V-D-J rearrangement but show individual nucleotide
differences; these differences are due to 
 
in vivo
 
 somatic
hypermutation events since the observed level of hypermutation
is far higher than the experimentally determined PCR error rate
for these methods (Dunn-Walters 
 
 et al.
 
, 1995). These duplicates
thus represent 
 
in vivo
 
 clonal expansions of an individual B-cell
family, and overall these data provide strong evidence for
oligoclonality (and thus a collapse in B-cell diversity) in those
samples with spectratypes of non-normal appearance.
 
The extent of loss in B-cell diversity correlates with 
health status in the elderly
 
The results presented above indicated that many of the NONA
individuals had distorted spectratypes whose SD was smaller,
or larger, than that generally seen for the young population
(Fig.  2c). To further explore our data we superimposed the
health status of each individual upon a plot of the SDs of the
NONA samples (Fig. 4). Initial visualization revealed that those
spectratypes whose SD values were atypically low or high when
compared to the mean SD for the control group were also the
samples from volunteers that had been classified as frail at the
time of sampling (Wikby 
 
 et al.
 
, 2002), whereas those classified
as healthy, or very healthy, generally had spectratype SD values
closer to the mean SD of the control group spectratypes
Fig. 2 Age effects on B-cell spectratypes. The line plots for B-cell spectratypes 
from peripheral blood mononuclear cells of 24 young (a, aged 19–55 years) 
and 32 old (b, aged 86–94 years) donors are overlaid to show the increased 
deviation from a normal distribution in some old samples. The dotted line 
overlaid on the plots represents the median distribution of the young control 
data set (aged 19–55 years). The SD values for each sample individually are 
shown, plotted against the donor’s age (c).
Fig. 3 Clonal expansions of B cells in samples with distorted spectratypes, but not in samples with normal spectratypes. The CDR3 regions, covering the IGHV-
IGHD-IGHJ joining regions of the immunoglobulin heavy chain gene, were cloned and sequenced from six samples. Sequences highlighted in red are examples 
of clonal expansions, with the same sequences found in different cloning reactions, or with evidence of intraclonal heterogeneity such as is created by somatic 
hypermutation during affinity maturation. The spectratype for each sample is shown next to the sequence grouping. Samples A and B are donors aged 95 
and 86, respectively, and who have normally-distributed spectratypes. Samples C, D, E and F were aged 90, 86, 86 and 95 years, respectively, and all had 
distorted spectratypes. 
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(Fig. 4a). This effect was seen for each of the three older age
groups individually (Fig. 4b).
To provide a single metric that is linearly related to this degree
of deviation from the expected SD, we therefore calculated the
difference (in absolute terms) between the sample SD and the
mean SD of the control group spectratypes. This metric, referred
to as 
 
Δ
 
SD, provides a singal value reflecting the degree of
distortion of a spectratype and thus diversity, with high values
associated with restricted diversity. Fig. 5(a) provides a different
summarization of Fig. 4, and demonstrates that an elevated
 
Δ
 
SD value is associated with frailty. The difference between the
frail group and the others is highly significant [
 
p
 
 < 0.0001 by
Mann–Whitney 
 
U
 
-test (MWU)]. The 
 
Δ
 
SD value is predictive of
fraility, with 
 
Δ
 
SD of greater than 1 predicting frailty with a
sensitivity of 0.78 and a specificity of 0.92 [as determined by
receiver operating characteristic (ROC) curve analysis].
Finally, since the blood samples had been taken several years
previously, it was possible to utilize follow-up data on survival
of the donors. This revealed that there was also a significant
difference in 
 
Δ
 
SD between those that survived longer than
4 years and those that died within 3 years after donating the
sample for analysis (
 
p
 
 < 0.05 by MWU, Fig. 5b). The medical
history was available for these individuals and we also found
an association between vitamin B12 deficiency and 
 
Δ
 
SD
(
 
p
 
 < 0.05 by MWU, Fig. 5c). There were no other associations
that reached significance.
 
Discussion
 
We have shown that we can measure B-cell diversity from
peripheral blood samples by a relatively simple method of PCR
and analysis of the resulting spectratype. Some very old
individuals show a dramatic reduction in B-cell diversity and this
is linked to frailty.
The link between the general health status of the individuals
in this study and their B-cell diversity is quite striking. Since the
general classification of ‘healthy’ was that the volunteers were
not medicated, institutionalized or demented (Wikby
 
 et  al.
 
,
2002), the definition of ‘frail’ in this instance goes well beyond
just immune frailty and susceptibility to infections. Thus, a collapse
in B-cell diversity seems to be a marker of overall frailty rather
than being specifically related to immune frailty. The complexity
of old age health makes it difficult to determine whether the
loss of B-cell diversity is a cause of frailty, or is a consequence
of a decline in health from other causes. With subjects of such
old age the medical histories could be quite complex, with co-
morbidity being a common occurrence. However, with the
exception of vitamin B12 deficiency, there were no significant
associations between 
 
Δ
 
SD and any particular illness. There was
a significant difference in 
 
Δ
 
SD between those patients who
were deficient in vitamin B12 and the others (
 
p
 
 = 0.026  by
MWU). This may be of relevance since vitamin B12 deficiency
can result in leucopenia (Andrès 
 
 et al.
 
, 2006). Since many old
people are vitamin B12 deficient, and supplementation is a
relatively simple treatment, it is important to elucidate the
relevance of this finding. Further studies would be needed to
determine whether there is a causative link between vitamin
B12 deficiency and loss of B-cell diversity, and whether leucocyte
diversity can be improved by restoration of normal vitamin B12
levels.
A reduced B-cell diversity is hypothesized to occur if the bone
marrow output of new cells is reduced. Since the overall number
of B cells does not change, reduced input of new B cells would
result in a greater proportion of antigen-experienced cells in the
population. The nature of a B-cell response, where the B-cell
population with receptor specific for antigen expands, means
that a repertoire made up of more antigen-experienced cells
would be expected to show evidence of clonality. This would
be evident in spectratypes, since expansion of one particular B-
cell clone means expansion of a particular size of CDR3 region.
To confirm this hypothesis, we sequenced the CDR3 regions
from a selection of samples and showed that we did indeed
see evidence of clonally related cells in cases where the spectra-
type was distorted, but not in cases where the spectratype
was normally distributed. It is not known whether bone marrow
output of B cells is reduced in old age in humans, but it has
been shown for mice (Cancro, 2005). It has also been shown
that, both in mice and humans, the proportion of memory
B cells increases with age (Williams 
 
 et al.
 
, 2000; Macallan 
 
 et al.
 
,
2005; Colonna-Romano 
 
 et al.
 
, 2006).
An alternative explanation for seeing distorted spectratypes
of B cells is of pathological expansions of B cells, such as are
Fig. 4 Visualization of the relationship between health status and spectratype 
SD. The SD of each spectratype was calculated as the measure of its distortion 
and then plotted vs. mean fragment length for ease of visualization (a). Each 
point is labelled according to the previously determined (Wikby et al., 2002) 
health data for the donors. vh, very healthy; h, healthy; f, frail. The majority 
of individuals that are ‘h’ or ‘vh’ have spectratype SDs that are close to mean 
SD value determined for the younger control group. In contrast, those 
samples with unusually low or high SDs are entirely those people classified 
as frail. This observation was independent of the age of the donor (b). 
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seen in leukaemia/lymphoma/monoclonal gammopathy. Individuals
with such a diagnosis were not included in this study; however,
the PCR method was originally developed as a sensitive test for
leukaemia or lymphoma and therefore we may pick up pre-
clinical conditions. An increase in monoclonal expansions of B
cells, both of CD5
 
+
 
 and CD5
 
–
 
 phenotype, has previously been
reported in older people (Ghia 
 
 et al.
 
, 2004). Monoclonal
gammopathy of undetermined significance (MGUS) is a pre-
dominant plasma-cell disorder, is characterized by an increase
in presence of serum monoclonal Ig, and has been shown to
increase with age (Ligthart 
 
 et al.
 
, 1990; Kyle 
 
 et al.
 
, 2006). Since
our cohort is very old, it is possible that MGUS accounts for
some of the observed repertoire restriction with increasing age.
However, our data do not suggest a high prevalence of such
monoclonal expansions, the restricted repertoires that we see
have a more oligoclonal appearance.
There was some correlation between our measures of B-cell
diversity and the IRP status of the subjects; of the seven subjects
classified as IRP positive, six had a 
 
Δ
 
SD greater than 1. However,
the 
 
Δ
 
SD appears to be a stronger predictor of health status than
IRP in this study. Six out of seven IRP-positive subjects were
classified as frail as compared with 13 out of 14 subjects with
a 
 
Δ
 
SD greater than 1 being classified as frail (confirmed by ROC
curve analysis, data not shown).
One immediate question arising from these findings is
whether a reduced B-cell diversity affects the ability of the
immune system to respond to challenge. We are commencing
a study to determine whether the quality of response to vacci-
nation is related to B-cell diversity. Since this method of analysis
is relatively simple, we could envisage its future use as a pre-
dictor of the quality of response to vaccines in older people,
thus enabling the identification of poor responders so that
alternative healthcare strategies can be considered.
 
Experimental procedures
 
Blood samples from cadaver donors, whose relatives had given
permission for general research use, were collected as part of
the normal tissue typing laboratory sampling procedures at
Guy’s Hospital, London, UK. Blood samples from old volunteers
were previously collected as part of the Swedish NONA–Immune
longitudinal study (Wikby 
 
 et al.
 
, 2002). Consent was obtained
according to the guidelines of the ethics committee of Linköping
University, Sweden.
DNA was extracted from peripheral blood mononuclear cells
using the QIAamp DNA blood mini kit (Qiagen, Crawley, UK) and
used at a concentration of approximately 100 ng 
 
μ
 
L
 
–1
 
 in PCRs.
The CDR3 region of the rearranged IGH gene (Fig. 1a) was ampli-
fied by adding 2 
 
μ
 
L of sample in a total volume of 25 
 
μ
 
L using
two rounds of PCR in a seminested fashion (Diss 
 
 et al.
 
, 1993)
with the following primers: Fw3 region 5
 
′
 
 primer, 5
 
′
 
-ACACG-
GCTGTGTATTACTGT-3
 
′
 
, IGHJ region 3
 
′
 
 primer 1, 5
 
′
 
-ACCTGAG-
GAGACGGTGACCAGGGT-3’, IGHJ region 3
 
′
 
 primer 2, 5
 
′
 
-
GTGACCAGGGTTCCTTGGCCCCAG-3
 
′
 
. The 3
 
′
 
 nested J region
primer 2 was labelled with the fluorescent marker 6-Fam. PCR
products were prepared for loading by adding 2 
 
μ
 
L of blue
loading dye, containing formamide, and 1 
 
μ
 
L of 1 : 2 diluted size
standard (350-TAMRA; Applied Biosystems, Warrington, UK) to 1 
 
μ
 
L
Fig. 5 Correlations with health and survival. The ΔSD value for each sample was determined as being the difference between the sample value and the mean 
control value. Donors had previously been classified as frail (f), healthy (h) or very healthy (vh) (Wikby et al., 2002). The difference between the healthy/very healthy 
and the frail was significant (p = 0.00006 by MWU), as was the difference between people who survived longer than 4 years and those that passed away within 
3 years (b, p = 0.035 by MWU). We also found a significant difference in ΔSD between patients with and without vitamin B12 deficiency (c, p = 0.026 by MWU). 
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of PCR product. Tubes were heated to 95–100 °C for between
2 and 5 min and then placed onto ice to denature the DNA.
The samples were run on a 6% denaturing polyacrylamide slab
sequencing gel on the ABI 377, according to manufacturer’s
instructions (Applied Biosystems). The results were saved to file
and analysed using GeneScan (Applied Biosystems) to determine
the peak sizes for each main peak in the spectratype. Since the
sequencing gel resolves to 1 bp, but the main peaks are every
3 bp (reflecting the predominance of open reading frame
rearrangements of IGH), we took the values for the peaks at
3-bp intervals for further analysis. These values were copied into
Microsoft Excel files which were imported and analysed further
in the R statistical programming environment (http://www.r-
project.org, R Development Core Team, 2006) to determine the
standard deviation of the spectratypes, calculate MWU values,
and perform ROC curve analysis. We have illustrated our
findings here using the standard deviation as the metric to
summarize the distributional distortions because it makes no
assumptions regarding the underlying distribution. However,
broadly similar conclusions were obtained when using skew,
kurtosis or a direct measure of correlation to normality as the
summarization metric (data not shown).
CDR3 PCR products from some of the spectratypes were
sequenced by LGC Agowa sequencing services after first
subcloning into the p-GEM®-T easy plasmid vector according
to manufacturer’s instructions (Promega, Southampton, UK).
Sequences were analysed to identify IGHD and IGHJ usage and
aligned using IMGT V-quest (Brochet  et al., 2008) and MegAlign
software (from the DNAStar software suite, Lasergene, Madison,
Wisconsin, USA).
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